OM1 Artifical Intelligence (AI) Shared Decision Aid Demonstrates Significant Improvement In Decision Quality And Surgical Outcomes For Knee Osteoarthritis
OM1 Artifical Intelligence (AI) Shared Decision Aid Demonstrates Significant Improvement In Decision Quality And Surgical Outcomes For Knee Osteoarthritis
BOSTON, Feb. 18, 2021 /PRNewswire/ -- OM1, a leading real-world data (RWD), health outcomes and technology company, today announced the publication of clinical trial results in JAMA Network Open demonstrating its tool, OM1â„¢ Joint Insights, positively impacts decision quality, shared decision making, patient experience, and functional outcomes in adults with knee osteoarthritis (OA).
波士頓，2021年2月18日/美通社/--領先的真實世界數據(RWD)、健康結果和技術公司OM1今天宣佈在JAMA Network Open上公佈臨牀試驗結果，展示其工具OM1？？聯合洞察力對成年膝骨性關節炎(OA)患者的決策質量、共同決策、患者體驗和功能結果產生積極影響。
AI SHARED DECISION AID DEMONSTRATES IMPROVEMENT IN DECISION QUALITY AND SURGICAL OUTCOMES FOR KNEE OSTEOARTHRITIS
AI共享決策AID顯示膝骨性關節炎決策質量和手術結果的改善
In the U.S., more than 30 million adults live with painful, immobilizing joint pain due to osteoarthritis, and more than one million total knee (TKR) and hip replacement (THR) surgeries are performed yearly. The treatment of musculoskeletal conditions in general, and osteoarthritis in particular, is characterized by a high health resource burden and substantial variability in choice of treatment and outcomes. TKR and THR procedures are primarily performed for pain relief and increased mobility.
在美國，3000多萬成年人因骨關節炎而生活在痛苦的、不能動彈的關節疼痛中，超過一每年進行百萬次全膝關節(TKR)和髖關節置換(THR)手術。一般肌肉骨骼疾病的治療，特別是骨關節炎的治療，其特點是衞生資源負擔高，治療和結果的選擇和結果有很大的變異性。TKR和THR手術主要是為了減輕疼痛和增加活動能力。
The randomized clinical trial (RCT) examined the impact of the OM1 Joint Insights tool, an artificial intelligence (AI)-enabled decision aid, including patient education, preference assessment, and personalized predictions of clinical outcomes compared to education only on decision quality, patient satisfaction, and functional outcomes among individuals with knee OA considering total knee replacement (TKR).
這項隨機臨牀試驗(RCT)檢驗了OM1聯合洞察工具(OM1 Joint Insights Tool)對考慮全膝關節置換術(TKR)的膝骨性關節炎患者的決策質量、患者滿意度和功能結果的影響。OM1聯合洞察工具是一種人工智能(AI)輔助決策工具，包括患者教育、偏好評估和對臨牀結果的個性化預測，而教育只對接受全膝關節置換(TKR)的膝骨性關節炎患者的決策質量、患者滿意度和功能結果產生影響。
Leveraging predictive models based on hundreds of thousands of past joint replacement surgeries, the OM1 Joint Insights tool generates personalized predictions of patients' likelihood of benefit and risk of serious complications from TKR. Joint Insights can also provide patients with education about knee OA and treatment options, test patient comfort with making a decision about surgery, and simulate benefit under different conditions.
OM1聯合洞察工具利用基於數十萬例過去關節置換手術的預測模型，對患者從TKR獲益的可能性和嚴重併發症的風險進行個性化預測。聯合洞察公司還可以為患者提供有關膝蓋骨關節炎和治療選擇的教育，測試患者在做出手術決定時的舒適度，並模擬不同條件下的益處。
"Advances in applying AI technologies to robust clinical data are enabling rapid advancement in generating personalized outcomes information," said Dr. Richard Gliklich, CEO of OM1. "This tool complements and augments the physician-patient decision-making process, giving a more quantitative, personalized picture of how each patient might respond to each possible treatment."
OM1首席執行官理查德·格里利希(Richard Gliklich)博士説：“在將人工智能技術應用於強大的臨牀數據方面的進步，使得在生成個性化結果信息方面取得了快速進步。”這一工具補充和增強了醫生-患者的決策過程，為每個患者可能如何對每種可能的治療做出反應提供了一幅更加量化、個性化的圖景。“
For more information, visit www.om1.com.
欲瞭解更多信息，請訪問www.om1.com。
Contact
聯繫人
Renee HurleyHead of Marketing, OM1617-620-9571rhurley@om1.com
營銷主管Renee Hurley電子郵件：OM1617-620-9571rhurley@om1.com
About OM1
關於OM1
With specialization in chronic conditions, OM1 is a health outcomes, data, and technology company using big clinical data and AI to better understand, compare, and predict patient outcomes. OM1's real-world evidence platforms, clinical registries and AI technologies enable clients to accelerate research, measure and benchmark health outcomes and to personalize patient care. Learn more at OM1.com.
OM1專注於慢性病，是一家使用大數據和人工智能來更好地理解、比較和預測患者結果的健康結果、數據和技術公司。OM1的真實證據平台、臨牀登記和人工智能技術使客户能夠加快研究、衡量和基準健康結果，並對患者進行個性化護理。欲瞭解更多信息，請訪問OM1.com。
View original content to download multimedia:http://www.prnewswire.com/news-releases/om1-artifical-intelligence-ai-shared-decision-aid-demonstrates-significant-improvement-in-decision-quality-and-surgical-outcomes-for-knee-osteoarthritis-301231185.html
查看原創內容以下載multimedia:http://www.prnewswire.com/news-releases/om1-artifical-intelligence-ai-shared-decision-aid-demonstrates-significant-improvement-in-decision-quality-and-surgical-outcomes-for-knee-osteoarthritis-301231185.html
SOURCE OM1
源OM1
譯文內容由第三人軟體翻譯。